chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Headache, Hypertension
Clinical narrative: Shortness of breath; Confused; Tightness in chest; Chest pain; Blood pressure high; Blood pressure increased from 106/72 mmhg to 140/90 mmHg; Headache; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Shortness of breath), CONFUSIONAL STATE (Confused), CHEST DISCOMFORT (Tightness in chest), CHEST PAIN (Chest pain) and HYPERTENSION (Blood pressure high) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESTRADIOL and GABAPENTIN for an unknown indication.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced DYSPNOEA (Shortness of breath), CONFUSIONAL STATE (Confused), CHEST DISCOMFORT (Tightness in chest), CHEST PAIN (Chest pain), HYPERTENSION (Blood pressure high) and HEADACHE (Headache). 27-May-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure increased from 106/72 mmhg to 140/90 mmHg). On 27-May-2021, DYSPNOEA (Shortness of breath), CONFUSIONAL STATE (Confused), CHEST DISCOMFORT (Tightness in chest), CHEST PAIN (Chest pain), HYPERTENSION (Blood pressure high), BLOOD PRESSURE INCREASED (Blood pressure increased from 106/72 mmhg to 140/90 mmHg) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2021, Blood pressure measurement: 140/90 mmHg (abnormal) following the first shot of vaccine BP  was 140/90. On 27-May-2021, Electrocardiogram: normal (normal) normal. On an unknown date, Blood pressure measurement: 106/72 mmHg (normal) her normal blood pressure was 106/72.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reported 20 minutes after vaccination shot she experienced the reported adverse events for 30 seconds. The patient was transported to the ER and was discharged within 2 hrs.  The treatment medications relevant to events were not reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Pyrexia
Clinical narrative: Feeling unwell; Temperature 38C/Temperature 38.4C; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell) and PYREXIA (Temperature 38C/Temperature 38.4C) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced MALAISE (Feeling unwell) and PYREXIA (Temperature 38C/Temperature 38.4C). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form and PARACETAMOL ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MALAISE (Feeling unwell) and PYREXIA (Temperature 38C/Temperature 38.4C) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 38, 38.4 (High) 38, 38.4.         No concomitant medication has been reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood thyroid stimulating hormone decreased, Chest pain, Decreased appetite, Dizziness
Clinical narrative: she was smoking more and she does that when she's anxious; Head whozzy; she lost 4 pounds after 2 weeks although she gained 1 pound today; Couldnt walk; TSH has dropped; Feeling so tired; Sore arm; no appetite; Chest pain; So wired i couln't calm down; This spontaneous case was reported by an other health care professional and describes the occurrence of ANXIETY (So wired i couln't calm down), CHEST PAIN (Chest pain), ANXIETY (she was smoking more and she does that when she's anxious), DIZZINESS (Head whozzy) and DECREASED APPETITE (no appetite) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Dec-2020, the patient experienced ANXIETY (So wired i couln't calm down). On 24-Dec-2020, the patient experienced CHEST PAIN (Chest pain), DECREASED APPETITE (no appetite), FATIGUE (Feeling so tired) and VACCINATION SITE PAIN (Sore arm). On an unknown date, the patient experienced ANXIETY (she was smoking more and she does that when she's anxious), DIZZINESS (Head whozzy), WEIGHT FLUCTUATION (she lost 4 pounds after 2 weeks although she gained 1 pound today), GAIT DISTURBANCE (Couldnt walk) and BLOOD THYROID STIMULATING HORMONE DECREASED (TSH has dropped). At the time of the report, ANXIETY (So wired i couln't calm down), CHEST PAIN (Chest pain), ANXIETY (she was smoking more and she does that when she's anxious), DIZZINESS (Head whozzy), DECREASED APPETITE (no appetite), WEIGHT FLUCTUATION (she lost 4 pounds after 2 weeks although she gained 1 pound today), GAIT DISTURBANCE (Couldnt walk), BLOOD THYROID STIMULATING HORMONE DECREASED (TSH has dropped), FATIGUE (Feeling so tired) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jan-2021: No new information
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Vaccination site pain, Weight fluctuation
Clinical narrative: she was smoking more and she does that when she's anxious; Head whozzy; she lost 4 pounds after 2 weeks although she gained 1 pound today; Couldnt walk; TSH has dropped; Feeling so tired; Sore arm; no appetite; Chest pain; So wired i couln't calm down; This spontaneous case was reported by an other health care professional and describes the occurrence of ANXIETY (So wired i couln't calm down), CHEST PAIN (Chest pain), ANXIETY (she was smoking more and she does that when she's anxious), DIZZINESS (Head whozzy) and DECREASED APPETITE (no appetite) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Dec-2020, the patient experienced ANXIETY (So wired i couln't calm down). On 24-Dec-2020, the patient experienced CHEST PAIN (Chest pain), DECREASED APPETITE (no appetite), FATIGUE (Feeling so tired) and VACCINATION SITE PAIN (Sore arm). On an unknown date, the patient experienced ANXIETY (she was smoking more and she does that when she's anxious), DIZZINESS (Head whozzy), WEIGHT FLUCTUATION (she lost 4 pounds after 2 weeks although she gained 1 pound today), GAIT DISTURBANCE (Couldnt walk) and BLOOD THYROID STIMULATING HORMONE DECREASED (TSH has dropped). At the time of the report, ANXIETY (So wired i couln't calm down), CHEST PAIN (Chest pain), ANXIETY (she was smoking more and she does that when she's anxious), DIZZINESS (Head whozzy), DECREASED APPETITE (no appetite), WEIGHT FLUCTUATION (she lost 4 pounds after 2 weeks although she gained 1 pound today), GAIT DISTURBANCE (Couldnt walk), BLOOD THYROID STIMULATING HORMONE DECREASED (TSH has dropped), FATIGUE (Feeling so tired) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jan-2021: No new information
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site pain, Vaccination site reaction, Vaccination site swelling
Clinical narrative: injection site reaction; Tendernes of the skin 2-3 inches from the injection site; Swelling of the skin 2-3 inches from the injection site; Redness on skin; This spontaneous case was reported by an other health care professional and describes the occurrence of ERYTHEMA (Redness on skin), VACCINATION SITE REACTION (injection site reaction), VACCINATION SITE PAIN (Tendernes of the skin 2-3 inches from the injection site) and VACCINATION SITE SWELLING (Swelling of the skin 2-3 inches from the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE PAIN (Tendernes of the skin 2-3 inches from the injection site) and VACCINATION SITE SWELLING (Swelling of the skin 2-3 inches from the injection site). In January 2021, the patient experienced ERYTHEMA (Redness on skin). On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site reaction). At the time of the report, ERYTHEMA (Redness on skin), VACCINATION SITE REACTION (injection site reaction), VACCINATION SITE PAIN (Tendernes of the skin 2-3 inches from the injection site) and VACCINATION SITE SWELLING (Swelling of the skin 2-3 inches from the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included  birth control pills No treatment medication were provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Hyperhidrosis, Myalgia
Clinical narrative: lacked apetite; weak all day; body aches; chills; hot sweats; light sensitivity; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (light sensitivity), DECREASED APPETITE (lacked apetite), HYPERHIDROSIS (hot sweats), ASTHENIA (weak all day) and MYALGIA (body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to Codeine), Blood pressure high since 2005, Vitreous floaters and Ocular Migraine (occurs less than twice a year) since 2008. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Blood pressure high, WOMENS MULTI ONE A DAY for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced PHOTOPHOBIA (light sensitivity), HYPERHIDROSIS (hot sweats), MYALGIA (body aches) and CHILLS (chills). On 05-May-2021, the patient experienced DECREASED APPETITE (lacked apetite) and ASTHENIA (weak all day). On 05-May-2021, PHOTOPHOBIA (light sensitivity) had resolved. On 06-May-2021, DECREASED APPETITE (lacked apetite), HYPERHIDROSIS (hot sweats), ASTHENIA (weak all day), MYALGIA (body aches) and CHILLS (chills) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   This case was linked to MOD-2021-068491 (Patient Link).
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Photophobia
Clinical narrative: lacked apetite; weak all day; body aches; chills; hot sweats; light sensitivity; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (light sensitivity), DECREASED APPETITE (lacked apetite), HYPERHIDROSIS (hot sweats), ASTHENIA (weak all day) and MYALGIA (body aches) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to Codeine), Blood pressure high since 2005, Vitreous floaters and Ocular Migraine (occurs less than twice a year) since 2008. Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) for Blood pressure high, WOMENS MULTI ONE A DAY for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-May-2021, the patient experienced PHOTOPHOBIA (light sensitivity), HYPERHIDROSIS (hot sweats), MYALGIA (body aches) and CHILLS (chills). On 05-May-2021, the patient experienced DECREASED APPETITE (lacked apetite) and ASTHENIA (weak all day). On 05-May-2021, PHOTOPHOBIA (light sensitivity) had resolved. On 06-May-2021, DECREASED APPETITE (lacked apetite), HYPERHIDROSIS (hot sweats), ASTHENIA (weak all day), MYALGIA (body aches) and CHILLS (chills) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   This case was linked to MOD-2021-068491 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest X-ray, Chest pain, Chills, Herpes zoster
Clinical narrative: Broke out in shingles; Chills; Fever 100.2F was with Tylenol; Horrible right chest pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills), PYREXIA (Fever 100.2F was with Tylenol), CHEST PAIN (Horrible right chest pain) and HERPES ZOSTER (Broke out in shingles) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included Shingles (she had shingles once before.). Concurrent medical conditions included Pneumonia and Shingles since 17-Apr-2021.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever 100.2F was with Tylenol). 16-Apr-2021, the patient experienced CHEST PAIN (Horrible right chest pain). On 17-Apr-2021, the patient experienced HERPES ZOSTER (Broke out in shingles). The patient was treated with PARACETAMOL (TYLENOL) on 16-Apr-2021 for Fever, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (Fever 100.2F was with Tylenol), CHEST PAIN (Horrible right chest pain) and HERPES ZOSTER (Broke out in shingles) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.2 (High) 4 hours after the vaccine she had fever of 100.2F. She took her temperature before the vaccine and it was 96.4 F.. On 17-Apr-2021, Herpes zoster: (Positive) The next day she broke out in shingles. On an unknown date, Chest X-ray: (abnormal) HCP is aware of the symptoms. He sent her for chest X-ray, they notice infiltrate right lower lobe..         Concomitant medications included patient is taking antibiotic for pneumonia. Patient stated that she is not comfortable taking the booster.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Broke out in shingles; Chills; Fever 100.2F was with Tylenol; Horrible right chest pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (Chills), PYREXIA (Fever 100.2F was with Tylenol), CHEST PAIN (Horrible right chest pain) and HERPES ZOSTER (Broke out in shingles) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included Shingles (she had shingles once before.). Concurrent medical conditions included Pneumonia and Shingles since 17-Apr-2021.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever 100.2F was with Tylenol). 16-Apr-2021, the patient experienced CHEST PAIN (Horrible right chest pain). On 17-Apr-2021, the patient experienced HERPES ZOSTER (Broke out in shingles). The patient was treated with PARACETAMOL (TYLENOL) on 16-Apr-2021 for Fever, at an unspecified dose and frequency. At the time of the report, CHILLS (Chills), PYREXIA (Fever 100.2F was with Tylenol), CHEST PAIN (Horrible right chest pain) and HERPES ZOSTER (Broke out in shingles) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.2 (High) 4 hours after the vaccine she had fever of 100.2F. She took her temperature before the vaccine and it was 96.4 F.. On 17-Apr-2021, Herpes zoster: (Positive) The next day she broke out in shingles. On an unknown date, Chest X-ray: (abnormal) HCP is aware of the symptoms. He sent her for chest X-ray, they notice infiltrate right lower lobe..         Concomitant medications included patient is taking antibiotic for pneumonia. Patient stated that she is not comfortable taking the booster.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: my left arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (my left arm is swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (my left arm is swollen). At the time of the report, PERIPHERAL SWELLING (my left arm is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatments were provided.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: So wired couln't calm down; This spontaneous case was reported by an other health care professional and describes the occurrence of ANXIETY (So wired couln't calm down) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (So wired couln't calm down). At the time of the report, ANXIETY (So wired couln't calm down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jan-2021: No new information was reported
Sex: F
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: So wired couln't calm down; This spontaneous case was reported by an other health care professional and describes the occurrence of ANXIETY (So wired couln't calm down) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (So wired couln't calm down). At the time of the report, ANXIETY (So wired couln't calm down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medication was provided. No treatment  was provided.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Side effects after receiving the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects after receiving the moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effects after receiving the moderna vaccine). At the time of the report, ADVERSE EVENT (Side effects after receiving the moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. Treatment information not provided.
Age: 58.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Unevaluable event
Clinical narrative: side effects/unevaluable event; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (side effects/unevaluable event) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product DUPILUMAB (DUPIXENT) for Atopic dermatitis.    Concurrent medical conditions included Atopic dermatitis.   In April 2021, the patient started DUPILUMAB (DUPIXENT) (Subcutaneous) 300 milligram every two weeks. On 19-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UNEVALUABLE EVENT (side effects/unevaluable event). At the time of the report, UNEVALUABLE EVENT (side effects/unevaluable event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No other concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Rash macular, Skin warm
Clinical narrative: arm has red blotches; arm is hot to the touch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (arm has red blotches) and SKIN WARM (arm is hot to the touch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (arm has red blotches) and SKIN WARM (arm is hot to the touch). At the time of the report, RASH MACULAR (arm has red blotches) and SKIN WARM (arm is hot to the touch) outcome was unknown.            No concomitant medications were provided. No treatment details were provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Right heel was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right heel was hurting) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Right heel was hurting). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Right heel was hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node in her clavicle area that is swollen and tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node in her clavicle area that is swollen and tender to touch) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph node in her clavicle area that is swollen and tender to touch). The patient was treated with IBUPROFEN for Swelling, at a dose of 1 UNK. At the time of the report, LYMPHADENOPATHY (Lymph node in her clavicle area that is swollen and tender to touch) outcome was unknown.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Pain, Pyrexia
Clinical narrative: not doing fine; achy; low grade fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not doing fine), PAIN (achy), PYREXIA (low grade fever) and FATIGUE (fatigue) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced MALAISE (not doing fine), PAIN (achy), PYREXIA (low grade fever) and FATIGUE (fatigue). At the time of the report, MALAISE (not doing fine), PAIN (achy), PYREXIA (low grade fever) and FATIGUE (fatigue) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable  No concomitant medications were reported  No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: report side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (report side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (report side effects). At the time of the report, VACCINATION COMPLICATION (report side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: Arm swelling; warm; red hives; itching approximately 2x2 inches in size; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelling), FEELING HOT (warm), URTICARIA (red hives) and PRURITUS (itching approximately 2x2 inches in size) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for Anticoagulant therapy, CALCIUM for Calcium supplementation, FISH OIL for Nutritional supplementation, MONASCUS PURPUREUS (RED YEAST RICE) for Supplementation therapy, VITAMIN C [ASCORBIC ACID] for Vitamin C supplementation, VITAMIN D [VITAMIN D NOS] for Vitamin D supplementation, ZINC for Zinc supplementation.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm swelling), FEELING HOT (warm), URTICARIA (red hives) and PRURITUS (itching approximately 2x2 inches in size). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (Arm swelling), FEELING HOT (warm), URTICARIA (red hives) and PRURITUS (itching approximately 2x2 inches in size) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also included ice.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue, Product administered to patient of inappropriate age
Clinical narrative: First shot on 15-Apr-2021, second shot not yet administered; 15yr old recived vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (First shot on 15-Apr-2021, second shot not yet administered) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15yr old recived vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2012, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15yr old recived vaccine). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (First shot on 15-Apr-2021, second shot not yet administered). On 15-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15yr old recived vaccine) had resolved. At the time of the report, INTENTIONAL PRODUCT USE ISSUE (First shot on 15-Apr-2021, second shot not yet administered) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.  The patient was doing fine.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow-up contains updated patient details and updated narrative.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: mild headaches; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (mild headaches) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), BIMATOPROST for Eye drop instillation, LISINOPRIL for Hypertension, SIMVASTATIN for Lipids NOS high, LEVOTHYROXINE SODIUM (SYNTHROID), CETIRIZINE, MULTIVITAMINS [VITAMINS NOS] and NITROFURANTOIN for an unknown indication.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced HEADACHE (mild headaches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at a dose of 1 dosage form. On 08-May-2021, HEADACHE (mild headaches) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: L arm Tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (L arm Tenderness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine and Multiple allergies (Unspecified). Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for Gastrointestinal disorder, ALPRAZOLAM (XANAX), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), VORTIOXETINE HYDROBROMIDE (TRINTELLIX) and BACLOFEN for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (L arm Tenderness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (L arm Tenderness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Other concomitant medicines included Loinzeff for gastrointestinal issues and migraine medicines which were stopped on 03-FEB-2021 advised by HCP to take once a month.   This case was linked to MOD-2021-039177 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Significant follow-up The event outcome was updated from unknown to recovered/resolved.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Axillary pain, Dizziness, Dry mouth, Eye movement disorder
Clinical narrative: burning pain in the arm all the way down to the wrist; tingly in all limbs; slightly elevated heart rate; taste is off; eyes are sensitive to light and sudden movement; eyes are sensitive to light and sudden movement; cotton dry mouth; Dizzy; injection site is painfully tender to the touch; nauseated; stinging pain in arm pit during injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off) and PHOTOPHOBIA (eyes are sensitive to light and sudden movement) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off), PHOTOPHOBIA (eyes are sensitive to light and sudden movement), EYE MOVEMENT DISORDER (eyes are sensitive to light and sudden movement), DRY MOUTH (cotton dry mouth), DIZZINESS (Dizzy), INJECTION SITE PAIN (injection site is painfully tender to the touch), NAUSEA (nauseated) and AXILLARY PAIN (stinging pain in arm pit during injection). At the time of the report, PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off), PHOTOPHOBIA (eyes are sensitive to light and sudden movement), EYE MOVEMENT DISORDER (eyes are sensitive to light and sudden movement), DRY MOUTH (cotton dry mouth), DIZZINESS (Dizzy), INJECTION SITE PAIN (injection site is painfully tender to the touch), NAUSEA (nauseated) and AXILLARY PAIN (stinging pain in arm pit during injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  No treatment medication was provided
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Injection site pain, Nausea, Pain in extremity, Paraesthesia
Clinical narrative: burning pain in the arm all the way down to the wrist; tingly in all limbs; slightly elevated heart rate; taste is off; eyes are sensitive to light and sudden movement; eyes are sensitive to light and sudden movement; cotton dry mouth; Dizzy; injection site is painfully tender to the touch; nauseated; stinging pain in arm pit during injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off) and PHOTOPHOBIA (eyes are sensitive to light and sudden movement) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off), PHOTOPHOBIA (eyes are sensitive to light and sudden movement), EYE MOVEMENT DISORDER (eyes are sensitive to light and sudden movement), DRY MOUTH (cotton dry mouth), DIZZINESS (Dizzy), INJECTION SITE PAIN (injection site is painfully tender to the touch), NAUSEA (nauseated) and AXILLARY PAIN (stinging pain in arm pit during injection). At the time of the report, PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off), PHOTOPHOBIA (eyes are sensitive to light and sudden movement), EYE MOVEMENT DISORDER (eyes are sensitive to light and sudden movement), DRY MOUTH (cotton dry mouth), DIZZINESS (Dizzy), INJECTION SITE PAIN (injection site is painfully tender to the touch), NAUSEA (nauseated) and AXILLARY PAIN (stinging pain in arm pit during injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  No treatment medication was provided
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Photophobia
Clinical narrative: burning pain in the arm all the way down to the wrist; tingly in all limbs; slightly elevated heart rate; taste is off; eyes are sensitive to light and sudden movement; eyes are sensitive to light and sudden movement; cotton dry mouth; Dizzy; injection site is painfully tender to the touch; nauseated; stinging pain in arm pit during injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off) and PHOTOPHOBIA (eyes are sensitive to light and sudden movement) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off), PHOTOPHOBIA (eyes are sensitive to light and sudden movement), EYE MOVEMENT DISORDER (eyes are sensitive to light and sudden movement), DRY MOUTH (cotton dry mouth), DIZZINESS (Dizzy), INJECTION SITE PAIN (injection site is painfully tender to the touch), NAUSEA (nauseated) and AXILLARY PAIN (stinging pain in arm pit during injection). At the time of the report, PAIN IN EXTREMITY (burning pain in the arm all the way down to the wrist), PARAESTHESIA (tingly in all limbs), HEART RATE INCREASED (slightly elevated heart rate), AGEUSIA (taste is off), PHOTOPHOBIA (eyes are sensitive to light and sudden movement), EYE MOVEMENT DISORDER (eyes are sensitive to light and sudden movement), DRY MOUTH (cotton dry mouth), DIZZINESS (Dizzy), INJECTION SITE PAIN (injection site is painfully tender to the touch), NAUSEA (nauseated) and AXILLARY PAIN (stinging pain in arm pit during injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  No treatment medication was provided
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchiness in the injection site; Broke out (like a rash) in the injection site; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), VACCINATION SITE PRURITUS (Itchiness in the injection site) and VACCINATION SITE RASH (Broke out (like a rash) in the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No medical history provided by the reporter.  Concomitant products included GABAPENTIN for Arthritis, OXYBUTYNIN for Bladder incontinence, DULOXETINE for Gastroesophageal reflux, PANTOPRAZOLE for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 13-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (Itchiness in the injection site) and VACCINATION SITE RASH (Broke out (like a rash) in the injection site). At the time of the report, PAIN IN EXTREMITY (Arm soreness), VACCINATION SITE PRURITUS (Itchiness in the injection site) and VACCINATION SITE RASH (Broke out (like a rash) in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment include Put gold bond cream    Reporter did not allow further contact
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate
Clinical narrative: lingering headaches; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (lingering headaches) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 048B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Acid reflux (esophageal) and Lipids NOS abnormal (Antilipidemic). Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), SIMVASTATIN for Cholesterol, LISINOPRIL for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID), CETIRIZINE, MULTIVITAMINS [VITAMINS NOS], NITROFURANTOIN and BIMATOPROST for an unknown indication.   On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced HEADACHE (lingering headaches). The patient was treated with PARACETAMOL (TYLENOL) for Headache NOS, at an unspecified dose and frequency and IBUPROFEN for Headache NOS, at an unspecified dose and frequency. At the time of the report, HEADACHE (lingering headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jun-2021, Heart rate: abnormal (abnormal) Heart rate going up and down at night..         This case was linked to MOD-2021-221236 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product discontinuation, Myalgia
Clinical narrative: Received Dose 2 on 14Apr2021; Left sore arm especially when lying on it; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION (Received Dose 2 on 14Apr2021) and MYALGIA (Left sore arm especially when lying on it) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 015M20A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included AMLODIPINE, ATENOLOL, METFORMIN, VITAMIN D [VITAMIN D NOS], ROSUVASTATIN, MECOBALAMIN (VITAMIN B12 [MECOBALAMIN]) and VITAMINS NOS for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION (Received Dose 2 on 14Apr2021) and MYALGIA (Left sore arm especially when lying on it). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION (Received Dose 2 on 14Apr2021) had resolved and MYALGIA (Left sore arm especially when lying on it) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-076941 (Patient Link).